10 results on '"Chang, K. C."'
Search Results
2. LBP-013 - Comparisons the durability of 6 months and 12 months prolonged treatment duration after cessation chemotherapy in chronic hepatitis B patients with prophylaxis antiviral therapy: A open level randomized clinical trial
3. P0337 : A polymorphism in IFNL3 is an independent risk factor for development of hepatocellular carcinoma after treatment of HCV infection
4. P566 THE CLINICAL-GUIDE RISK PREDICTION MODEL OF HEPATOCELLULAR CARCINOMA DEVELOPMENT IN CHRONIC HEPATITIS C PATIENTS AFTER INTERFERON-BASED THERAPY
5. 648 VALIDATION OF 2010 AASLD GUIDELINE IN THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA FOR NON-CIRRHOTIC LIVER
6. 828 ROLE OF HEPATITIS C VIRUS SUBSTITUTIONS AND INTERLEUKIN 28B POLYMORPHISM ON RESPONSE TO PEGINTERFERON PLUS RIBAVIRIN IN A PROSPECTIVE STUDY OF RESPONSE-GUIDED THERAPY
7. 717 THE EXPRESSION AND PROGNOSTIC ROLE OF CHIBBY GENE IN HUMAN HEPATOPCELLULAR CARCINOMA
8. 1097 INDEPENDENT RISK FACTORS AND PREDICTIVE SCORE FOR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS C AFTER SUSTAINED RESPONSE TO PEGINTERFERON AND RIBAVIRIN COMBINATION THERAPY
9. 408 RISK FACTORS FOR DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C AFTER SUSTAINED RESPONSE TO PEGINTERFERON AND RIBAVIRIN COMBINATION THERAPY
10. 752 EFFICACY AND SAFETY OF ENTECAVIR FOR TREATMENT OF CHRONIC HEPATITIS B IN NUCLEOS(T)IDE NAIVE AND LAMIVUDINE EXPERIENCED RENAL TRANSPLANT RECIPIENTS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.